Wang, Qizhang <br/><br/>
Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway.  [electronic resource] 

 -  Medical science monitor : international medical journal of experimental and clinical research  Jan 2019 
 - 700-710 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1643-3750 
<br/><br/><label>Standard No.: </label>10.12659/MSM.911579  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--drug therapy<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Endothelial Cells--drug effects<br/>Epidermal Growth Factor--metabolism<br/>ErbB Receptors--drug effects<br/>Human Umbilical Vein Endothelial Cells--drug effects<br/>Humans<br/>Keratinocytes--drug effects<br/>Neovascularization, Pathologic--metabolism<br/>Neovascularization, Physiologic--drug effects<br/>Nitric Oxide Synthase Type III--metabolism<br/>Phosphatidylinositol 3-Kinases--drug effects<br/>Proto-Oncogene Proteins c-akt--drug effects<br/>Signal Transduction--drug effects<br/>Zoledronic Acid--pharmacology